ConductScience.org, home

Paper36944864

Real-World Analysis of Clinical Characteristics, Treatment Patterns, and Patient-Reported Outcomes of Insufficient Responders and Responders to Prescribed Acute Migraine Treatment in China.

Zhang L and 8 others. Pain Ther, 2023. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Real-World Analysis of Clinical Characteristics, Treatment Patterns, and Patient-Reported Outcomes of Insufficient Responders and Responders to Prescribed Acute Migraine Treatment in China. Papers, record 36944864. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36944864

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Real-World Analysis of Clinical Characteristics, Treatment Patterns, and Patient-Reported Outcomes of Insufficient Responders and Responders to Prescribed Acute Migraine Treatment in China.
PubMed
Journal
Pain Ther
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.58
iCite
Revised in PubMed
2023-07-29
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang LLei
2Novick DDiego
3Zhong SShiyinghttps://orcid.org/0000-0002-4425-5326
4Li JJinnanhttps://orcid.org/0000-0002-8393-3118
5Walker CChloe
6Harrison LLewis
7Jackson JJameshttps://orcid.org/0000-0002-4171-5390
8Barlow SSophie
9Cotton SSarah

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134145431Diagnosis and management of migraine in ten steps.Nat Rev Neurol2021https://conductscience.org/library/papers/34145431PubMed
231699022Burden of headache disorders in China, 1990-2017: findings from the Global Burden of Disease Study 2017.J Headache Pain2019https://conductscience.org/library/papers/31699022PubMed
332404048Migraine treatment and healthcare costs: retrospective analysis of the China Health Insurance Research Association (CHIRA) database.J Headache Pain2020https://conductscience.org/library/papers/32404048PubMed
430806518Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition.Cephalalgia2019https://conductscience.org/library/papers/30806518PubMed
529556965Targeted CGRP Small Molecule Antagonists for Acute Migraine Therapy.Neurotherapeutics2018https://conductscience.org/library/papers/29556965PubMed
623879870Examination of unmet treatment needs among persons with episodic migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study.Headache2013https://conductscience.org/library/papers/23879870PubMed
731410844Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study.Headache2019https://conductscience.org/library/papers/31410844PubMed
832510611A Real-World Analysis of Patient Characteristics, Treatment Patterns, and Level of Impairment in Patients With Migraine Who are Insufficient Responders vs Responders to Acute Treatment.Headache2020https://conductscience.org/library/papers/32510611PubMed
932641075Factors associated with insufficient response to acute treatment of migraine in Japan: analysis of real-world data from the Adelphi Migraine Disease Specific Programme.BMC Neurol2020https://conductscience.org/library/papers/32641075PubMed
1025773005Drug safety in acute migraine treatment.Expert Opin Drug Saf2015https://conductscience.org/library/papers/25773005PubMed
1112864756Migraine medication attributes important for patient compliance: concerns about side effects may delay treatment.Headache2003https://conductscience.org/library/papers/12864756PubMed
1231174999Pathophysiology, prevention, and treatment of medication overuse headache.Lancet Neurol2019https://conductscience.org/library/papers/31174999PubMed
1318826746Real-world physician and patient behaviour across countries: Disease-Specific Programmes - a means to understand.Curr Med Res Opin2008https://conductscience.org/library/papers/18826746PubMed
1427531722Evidence for validity of a national physician and patient-reported, cross-sectional survey in China and UK: the Disease Specific Programme.BMJ Open2016https://conductscience.org/library/papers/27531722PubMed
1527843332Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015.Diabetes Metab Syndr Obes2016https://conductscience.org/library/papers/27843332PubMed
1610214536Reliability of the migraine disability assessment score in a population-based sample of headache sufferers.Cephalalgia1999https://conductscience.org/library/papers/10214536PubMed
1711294956Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability.Neurology2001https://conductscience.org/library/papers/11294956PubMed
1810146874The validity and reproducibility of a work productivity and activity impairment instrument.Pharmacoeconomics1993https://conductscience.org/library/papers/10146874PubMed
1911966858What do patients with migraine want from acute migraine treatment?Headache2002https://conductscience.org/library/papers/11966858PubMed
2023731663Health-care utilization for primary headache disorders in China: a population-based door-to-door survey.J Headache Pain2013https://conductscience.org/library/papers/23731663PubMed

See all 35 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
41109979A Phase 1 Open-Label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Intranasal Dose of Zavegepant in Healthy Chinese Adults.Clin Pharmacol Drug Dev2026https://conductscience.org/library/papers/41109979PubMed
39416954Modulating oxidative stress and neurogenic inflammation: the role of topiramate in migraine treatment.Front Aging Neurosci2024https://conductscience.org/library/papers/39416954PubMed
39333875First real-world study on the effectiveness and tolerability of rimegepant for acute migraine therapy in Chinese patients.J Headache Pain2024https://conductscience.org/library/papers/39333875PubMed
38627638Rimegepant orally disintegrating tablet 75 mg for acute treatment of migraine in adults from China: a subgroup analysis of a double-blind, randomized, placebo-controlled, phase 3 clinical trial.J Headache Pain2024https://conductscience.org/library/papers/38627638PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36944864

GET https://conductscience.org/api/papers/v1/36944864/references?page=2